nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—Diabetes insipidus—Riluzole—amyotrophic lateral sclerosis	0.0544	0.107	CcSEcCtD
Octreotide—SSTR5—hindbrain—amyotrophic lateral sclerosis	0.034	0.106	CbGeAlD
Octreotide—SSTR3—hindbrain—amyotrophic lateral sclerosis	0.0326	0.102	CbGeAlD
Octreotide—SSTR1—hindbrain—amyotrophic lateral sclerosis	0.0257	0.0805	CbGeAlD
Octreotide—SSTR2—hindbrain—amyotrophic lateral sclerosis	0.0219	0.0684	CbGeAlD
Octreotide—SSTR5—brainstem—amyotrophic lateral sclerosis	0.0195	0.0608	CbGeAlD
Octreotide—SSTR3—brainstem—amyotrophic lateral sclerosis	0.0187	0.0583	CbGeAlD
Octreotide—SSTR1—brainstem—amyotrophic lateral sclerosis	0.0148	0.0461	CbGeAlD
Octreotide—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0138	0.027	CcSEcCtD
Octreotide—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.0138	0.027	CcSEcCtD
Octreotide—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0132	0.026	CcSEcCtD
Octreotide—SSTR2—brainstem—amyotrophic lateral sclerosis	0.0125	0.0392	CbGeAlD
Octreotide—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0245	CcSEcCtD
Octreotide—SSTR4—nervous system—amyotrophic lateral sclerosis	0.012	0.0375	CbGeAlD
Octreotide—SSTR4—central nervous system—amyotrophic lateral sclerosis	0.0116	0.0361	CbGeAlD
Octreotide—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0215	CcSEcCtD
Octreotide—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0215	CcSEcCtD
Octreotide—SSTR3—nervous system—amyotrophic lateral sclerosis	0.00978	0.0306	CbGeAlD
Octreotide—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00976	0.0191	CcSEcCtD
Octreotide—SSTR5—cerebellum—amyotrophic lateral sclerosis	0.0096	0.03	CbGeAlD
Octreotide—SSTR3—central nervous system—amyotrophic lateral sclerosis	0.00942	0.0294	CbGeAlD
Octreotide—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00939	0.0184	CcSEcCtD
Octreotide—SSTR3—cerebellum—amyotrophic lateral sclerosis	0.0092	0.0288	CbGeAlD
Octreotide—SSTR4—brain—amyotrophic lateral sclerosis	0.00917	0.0287	CbGeAlD
Octreotide—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00893	0.0175	CcSEcCtD
Octreotide—SSTR4—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00778	0.0458	CbGpPWpGaD
Octreotide—SSTR1—nervous system—amyotrophic lateral sclerosis	0.00773	0.0242	CbGeAlD
Octreotide—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0148	CcSEcCtD
Octreotide—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0148	CcSEcCtD
Octreotide—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0148	CcSEcCtD
Octreotide—SSTR3—brain—amyotrophic lateral sclerosis	0.00748	0.0234	CbGeAlD
Octreotide—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0146	CcSEcCtD
Octreotide—SSTR1—central nervous system—amyotrophic lateral sclerosis	0.00744	0.0233	CbGeAlD
Octreotide—SSTR1—cerebellum—amyotrophic lateral sclerosis	0.00728	0.0227	CbGeAlD
Octreotide—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00718	0.0141	CcSEcCtD
Octreotide—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00687	0.0135	CcSEcCtD
Octreotide—SSTR2—nervous system—amyotrophic lateral sclerosis	0.00657	0.0205	CbGeAlD
Octreotide—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00638	0.0125	CcSEcCtD
Octreotide—SSTR2—central nervous system—amyotrophic lateral sclerosis	0.00633	0.0198	CbGeAlD
Octreotide—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0122	CcSEcCtD
Octreotide—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00619	0.0121	CcSEcCtD
Octreotide—SSTR2—cerebellum—amyotrophic lateral sclerosis	0.00619	0.0193	CbGeAlD
Octreotide—SSTR1—brain—amyotrophic lateral sclerosis	0.00591	0.0185	CbGeAlD
Octreotide—SSTR3—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.0059	0.0347	CbGpPWpGaD
Octreotide—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0115	CcSEcCtD
Octreotide—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0115	CcSEcCtD
Octreotide—SSTR1—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00565	0.0333	CbGpPWpGaD
Octreotide—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00564	0.0111	CcSEcCtD
Octreotide—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00564	0.0111	CcSEcCtD
Octreotide—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00513	0.0101	CcSEcCtD
Octreotide—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0051	0.01	CcSEcCtD
Octreotide—SSTR2—brain—amyotrophic lateral sclerosis	0.00502	0.0157	CbGeAlD
Octreotide—SSTR5—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00502	0.0295	CbGpPWpGaD
Octreotide—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00961	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00483	0.0284	CbGpPWpGaD
Octreotide—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00924	CcSEcCtD
Octreotide—SSTR2—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00463	0.0272	CbGpPWpGaD
Octreotide—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00848	CcSEcCtD
Octreotide—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0084	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0084	CcSEcCtD
Octreotide—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00817	CcSEcCtD
Octreotide—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00805	CcSEcCtD
Octreotide—Injury—Riluzole—amyotrophic lateral sclerosis	0.00405	0.00795	CcSEcCtD
Octreotide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00396	0.00777	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00395	0.0233	CbGpPWpGaD
Octreotide—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00755	CcSEcCtD
Octreotide—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00752	CcSEcCtD
Octreotide—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0073	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0073	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00366	0.0215	CbGpPWpGaD
Octreotide—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00713	CcSEcCtD
Octreotide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00679	CcSEcCtD
Octreotide—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00646	CcSEcCtD
Octreotide—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00644	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00328	0.0193	CbGpPWpGaD
Octreotide—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00636	CcSEcCtD
Octreotide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00631	CcSEcCtD
Octreotide—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00631	CcSEcCtD
Octreotide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00619	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00311	0.0183	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00311	0.0183	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00311	0.0183	CbGpPWpGaD
Octreotide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00607	CcSEcCtD
Octreotide—SSTR4—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00309	0.0182	CbGpPWpGaD
Octreotide—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00605	CcSEcCtD
Octreotide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0059	CcSEcCtD
Octreotide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00583	CcSEcCtD
Octreotide—MPO—spinal cord—amyotrophic lateral sclerosis	0.00295	0.00923	CbGeAlD
Octreotide—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00575	CcSEcCtD
Octreotide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00571	CcSEcCtD
Octreotide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00566	CcSEcCtD
Octreotide—Depression—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00561	CcSEcCtD
Octreotide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00552	CcSEcCtD
Octreotide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00549	CcSEcCtD
Octreotide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00547	CcSEcCtD
Octreotide—SSTR3—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00277	0.0163	CbGpPWpGaD
Octreotide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00537	CcSEcCtD
Octreotide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00532	CcSEcCtD
Octreotide—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00531	CcSEcCtD
Octreotide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00528	CcSEcCtD
Octreotide—SSTR1—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00266	0.0156	CbGpPWpGaD
Octreotide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00514	CcSEcCtD
Octreotide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00507	CcSEcCtD
Octreotide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00505	CcSEcCtD
Octreotide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00503	CcSEcCtD
Octreotide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00502	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00255	0.015	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00255	0.015	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00255	0.015	CbGpPWpGaD
Octreotide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00498	CcSEcCtD
Octreotide—MPO—nervous system—amyotrophic lateral sclerosis	0.00249	0.00778	CbGeAlD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00246	0.0144	CbGpPWpGaD
Octreotide—MPO—central nervous system—amyotrophic lateral sclerosis	0.0024	0.00749	CbGeAlD
Octreotide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00469	CcSEcCtD
Octreotide—SSTR5—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00236	0.0139	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00234	0.0138	CbGpPWpGaD
Octreotide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00456	CcSEcCtD
Octreotide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00451	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.0023	0.0135	CbGpPWpGaD
Octreotide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00447	CcSEcCtD
Octreotide—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00443	CcSEcCtD
Octreotide—SSTR1—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00224	0.0132	CbGpPWpGaD
Octreotide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0044	CcSEcCtD
Octreotide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00433	CcSEcCtD
Octreotide—Tension—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00432	CcSEcCtD
Octreotide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00427	CcSEcCtD
Octreotide—SSTR2—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00218	0.0128	CbGpPWpGaD
Octreotide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00425	CcSEcCtD
Octreotide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00423	CcSEcCtD
Octreotide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00412	CcSEcCtD
Octreotide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00408	CcSEcCtD
Octreotide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00407	CcSEcCtD
Octreotide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00404	CcSEcCtD
Octreotide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00397	CcSEcCtD
Octreotide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00395	CcSEcCtD
Octreotide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00394	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00199	0.0117	CbGpPWpGaD
Octreotide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00389	CcSEcCtD
Octreotide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00387	CcSEcCtD
Octreotide—Cough—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00384	CcSEcCtD
Octreotide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00381	CcSEcCtD
Octreotide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0038	CcSEcCtD
Octreotide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00374	CcSEcCtD
Octreotide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00374	CcSEcCtD
Octreotide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00374	CcSEcCtD
Octreotide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00373	CcSEcCtD
Octreotide—MPO—brain—amyotrophic lateral sclerosis	0.0019	0.00595	CbGeAlD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00372	CcSEcCtD
Octreotide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0037	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00187	0.011	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00187	0.011	CbGpPWpGaD
Octreotide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00366	CcSEcCtD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00186	0.0109	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00184	0.0108	CbGpPWpGaD
Octreotide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00359	CcSEcCtD
Octreotide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00359	CcSEcCtD
Octreotide—Infection—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00357	CcSEcCtD
Octreotide—Shock—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00353	CcSEcCtD
Octreotide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00352	CcSEcCtD
Octreotide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00352	CcSEcCtD
Octreotide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0035	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00178	0.0105	CbGpPWpGaD
Octreotide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00349	CcSEcCtD
Octreotide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00347	CcSEcCtD
Octreotide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00342	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.0017	0.00997	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00327	CcSEcCtD
Octreotide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00325	CcSEcCtD
Octreotide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00322	CcSEcCtD
Octreotide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0032	CcSEcCtD
Octreotide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00319	CcSEcCtD
Octreotide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00316	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00161	0.00947	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.0016	0.0094	CbGpPWpGaD
Octreotide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00312	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00158	0.0093	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0031	CcSEcCtD
Octreotide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0031	CcSEcCtD
Octreotide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00307	CcSEcCtD
Octreotide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00307	CcSEcCtD
Octreotide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00296	CcSEcCtD
Octreotide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00294	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00149	0.00874	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00146	0.00859	CbGpPWpGaD
Octreotide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00285	CcSEcCtD
Octreotide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00284	CcSEcCtD
Octreotide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00284	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00142	0.00833	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00136	0.00799	CbGpPWpGaD
Octreotide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00264	CcSEcCtD
Octreotide—SSTR4—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00135	0.00793	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00132	0.00775	CbGpPWpGaD
Octreotide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00258	CcSEcCtD
Octreotide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00254	CcSEcCtD
Octreotide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00246	CcSEcCtD
Octreotide—SSTR3—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00121	0.00712	CbGpPWpGaD
Octreotide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00237	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.0012	0.00709	CbGpPWpGaD
Octreotide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00228	CcSEcCtD
Octreotide—SSTR1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00116	0.00683	CbGpPWpGaD
Octreotide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00226	CcSEcCtD
Octreotide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00226	CcSEcCtD
Octreotide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00225	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00111	0.00654	CbGpPWpGaD
Octreotide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00213	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00107	0.0063	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00106	0.00621	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00103	0.00605	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00102	0.00601	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000979	0.00576	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000959	0.00564	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00095	0.00559	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000869	0.00511	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000816	0.0048	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000812	0.00478	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000805	0.00473	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000802	0.00471	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000801	0.00471	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000779	0.00458	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000779	0.00458	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000768	0.00451	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000751	0.00442	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000748	0.0044	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000727	0.00428	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000703	0.00414	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000697	0.0041	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000691	0.00406	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000683	0.00402	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000681	0.004	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000667	0.00392	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000659	0.00387	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000646	0.0038	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000637	0.00375	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000628	0.0037	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000618	0.00364	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000618	0.00364	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000593	0.00349	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000573	0.00337	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000571	0.00336	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000567	0.00333	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000567	0.00333	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000563	0.00331	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000559	0.00329	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000543	0.0032	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000533	0.00313	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000526	0.00309	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000511	0.003	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000505	0.00297	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000489	0.00288	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000485	0.00285	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000484	0.00285	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000482	0.00283	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000474	0.00279	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000469	0.00276	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000461	0.00271	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000453	0.00266	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000445	0.00262	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000434	0.00255	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00043	0.00253	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00043	0.00253	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000419	0.00246	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000418	0.00246	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000416	0.00245	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000416	0.00245	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000412	0.00242	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000396	0.00233	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000389	0.00229	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000384	0.00226	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000369	0.00217	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000365	0.00215	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000365	0.00215	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000359	0.00211	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000349	0.00206	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000348	0.00205	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000344	0.00202	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000341	0.002	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000337	0.00198	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000335	0.00197	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000317	0.00187	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000305	0.0018	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000304	0.00179	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000298	0.00175	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000297	0.00175	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000295	0.00174	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000283	0.00166	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000282	0.00166	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00028	0.00165	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000277	0.00163	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000274	0.00161	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.00027	0.00159	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000265	0.00156	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000264	0.00155	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000253	0.00149	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000251	0.00148	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000249	0.00146	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000247	0.00145	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000235	0.00138	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000232	0.00136	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.00023	0.00135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000226	0.00133	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000224	0.00132	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000217	0.00128	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000216	0.00127	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000212	0.00125	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000207	0.00122	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000203	0.0012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000192	0.00113	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.00019	0.00112	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000187	0.0011	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00018	0.00106	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00018	0.00106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000177	0.00104	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000175	0.00103	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000167	0.000984	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000166	0.000979	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000159	0.000938	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000148	0.000873	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000147	0.000865	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000146	0.000862	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000144	0.000848	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000138	0.000814	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000138	0.000813	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000137	0.000806	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000124	0.000731	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000123	0.000721	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000113	0.000666	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000111	0.000653	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000106	0.000626	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000105	0.000617	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000101	0.000592	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.44e-05	0.000555	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.42e-05	0.000554	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.39e-05	0.000552	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.03e-05	0.000531	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.92e-05	0.000525	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.71e-05	0.000512	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.23e-05	0.000484	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.01e-05	0.000471	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.39e-05	0.000435	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.12e-05	0.000419	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.82e-05	0.000401	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.05e-05	0.000356	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.59e-05	0.000329	CbGpPWpGaD
